卵巢癌的靶向治疗

卵巢癌的靶向治疗

ID:11944655

大小:4.06 MB

页数:18页

时间:2018-07-15

卵巢癌的靶向治疗_第1页
卵巢癌的靶向治疗_第2页
卵巢癌的靶向治疗_第3页
卵巢癌的靶向治疗_第4页
卵巢癌的靶向治疗_第5页
资源描述:

《卵巢癌的靶向治疗》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、Saturday,February7,20091:00PM-2:30PMSanAntonioMarriottRiverwalk BallroomLevel SalonABCSanAntonio,TexasBeyondChemotherapy:CurrentandFutureMolecular-TargetedTherapyinOvarianCancerThisprogramissupportedbyaneducationalgrantfromMichaelV.Seiden,MD,PhDPresidentandChiefExecutiveOfficerFoxChaseCancerCen

2、ter Philadelphia,PennsylvaniaTheNeedforMolecular-TargetedTherapyGOG111:StandardofCareStudydesignCisplatin135mg2IVover24hours+Paclitaxel75mg/m2x6cycles(n=184)Cisplatin75mg/m2x6cycles+Cyclophosphamide750mg/m2IV(n=202)Patientswithsuboptimallydebulked,stageIII/IVepithelialovariancancerwithin6weekso

3、f surgery(N=386)McGuireW,etal.NEnglJMed.1996;334:1-6.GOG111:PFSandOSMcGuireW,etal.NEnglJMed.1996;334:1-6.TreatmentNo.Progression FreeNo.WithTreatmentFailureTotalMedian PFS,mosCisplatin+ cyclophosphamide2817420213Cisplatin+paclitaxel451391841800.10.20.30.40.50.60.70.80.91.0MonthsAfterEntryIntoSt

4、udyProportionSurvivingProgressionFree062436421218304800.10.20.30.40.50.60.70.80.91.0MonthsAfterEntryIntoStudyProportionSurviving0624364212183048TreatmentNo.AliveNo.DeadTotalMedian Survival,mosCisplatin+ cyclophosphamide6513720224Cisplatin+paclitaxel869818438PFS(P<.001)OS(P<.001)GOG218:Potential

5、NewStandard ofCarePrimaryendpoint:PFSmeasuredbyRECISTSecondaryendpoints:OS,safety,QoL,translationalobjectives,response*Beginningincourse2ofchemotherapy.†Beginningincourse7ofchemotherapy.ClinicalTrials.gov.NCT00262847.PatientswithstageIII/IVovarianorprimaryperitonealcancerandGOGPS0-2entered1-12w

6、eeksafterinitialsurgery(N=2000)Paclitaxel+Carboplatin+Placebo*Paclitaxel+Carboplatin+Bevacizumab*Paclitaxel+Carboplatin+Bevacizumab*Placebo†x15monthsPlacebo†x15monthsBevacizumab†x15monthsTCGAandPredictiveMarkersTheCancerGenomeAtlasprojectCollaborationofNCIandNationalHumanGenomeResearchInstitute

7、MultidisciplinaryeffortaimedatdevelopingandevaluatingasystemforidentifyingandcharacterizinggenomicchangesassociatedwithGBM,lungcancer,andserouscanceroftheovariesOvariancancerdatanowpopulatingTheCancerGenomeAtlasdatabaseOvarianCanc

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。